Association of p16 (CDKN2A) polymorphisms with the development of HPV16-related precancerous lesions and cervical cancer in the Greek population
Ημερομηνία
2018Γλώσσα
en
Λέξη-κλειδί
Επιτομή
The tumor suppressor protein p16 plays a fundamental role in cell cycle regulation and exerts a protective effect against tumor growth. Two different polymorphisms at positions 540 and 580 at the 3′UTR of exon 3 of p16 gene are implicated in several types of cancer, while their role in cervical cancer development remains rather vague. In the present study, we investigated for the impact of p16 genotypes/haplotypes on patients' vulnerability to cervical disease and examined whether these factors can be used as progression markers in the Greek population. A total of 96 HPV16 positive samples and histologically confirmed as LSIL (42 samples), HSIL (44 samples), and cervical cancer cases (10 samples) along with 50 control cases were tested. The identification of p16 polymorphisms was performed by PCR-RFLP methodology. The present analysis revealed that women with p16 540 CG/GG genotype are at a 2.7-fold higher risk of developing HPV16-associated HSIL (OR = 2.7, 95%CI: 1.01-6.6, P = 0.028). The G allele can be regarded as a risk factor of developing HSIL in the Greek population (OR = 2.7, 95%CI: 1.2-5.9, P = 0.012). Moreover, p16 polymorphism C580T is not associated with the growth of cervical lesion in Greek patients, while 540G/580C haplotype can be regarded as a risk haplotype of developing HSIL (OR = 3.67, 95%CI: 1.56-8.6, P = 0.0019). Our results demonstrated that p16 C540G polymorphism influence patients' susceptibility to more severe dysplasia and consequently this polymorphism could potentially emerge as a valuable biomarker for HSIL development in the Greek population. © 2017 Wiley Periodicals, Inc.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network across Rural Greece: The Grecoself study
Agorastos T., Chatzistamatiou K., Tsertanidou A., Mouchtaropoulou E., Pasentsis K., Kitsou A., Moysiadis T., Moschaki V., Skenderi A., Katsiki E., Aggelidou S., Venizelos I., Ntoula M., Daponte A., Vanakara P., Garas A., Stefos T., Vrekoussis T., Lymberis V., Kontomanolis E.N., Makrigiannakis A., Manidakis G., Deligeoroglou E., Panoskaltsis T., Decavalas G.O., Michail G., Kalogiannidis I., Koukoulis G., Zempili P., Halatsi D., Truva T., Piha V., Agelena G., Chronopoulou A., Vaitsi V., Chatzaki E., Paschopoulos M., Adonakis G., Kaufmann A.M., Hadzidimitriou A., Stamatopoulos K. (2019)Self-sampling for human papillomavirus (HPV) testing is an alternative to physician sampling particularly for cervical cancer screening nonattenders. The GRECOSELF study is a nationwide observational cross-sectional study ... -
Polymorphic variability in the exon 19 of the RB1 gene and its flanking intronic sequences in HPV16-associated precancerous lesions in the Greek population
Tsakogiannis D., Moschonas G.D., Daskou M., Stylianidou Z., Kyriakopoulou Z., Kottaridi C., Dimitriou T.G., Gartzonika C., Markoulatos P. (2018)Purpose. The tumour suppressor protein RB plays a decisive role in negative control of the cell cycle, inhibiting tumour development. The present analysis investigated the prevalence of the nucleotide polymorphism A153104G, ... -
Genetic variability of the HPV16 early genes and LCR. Present and future perspectives
Bletsa G., Zagouri F., Amoutzias G.D., Nikolaidis M., Zografos E., Markoulatos P., Tsakogiannis D. (2021)Human papillomavirus 16 (HPV16) infection is the aetiologic factor for the development of cervical dysplasia and is regarded as highly carcinogen, because it is implicated in more than 50% of cervical cancer cases, worldwide. ...